Metraipolis › archive › dc_3be38afef8ea

JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence — Europe PMC PMID:42459674

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42459674
DOI: 10.3389/fimmu.2026.1784714
License (as archived): solo-consultazione
Archived: 2026-10-18T14:12:17.314Z
SHA-256 of the archived text: b1aad7627436a4d820ab409663ac5f4d10db3ac6424dead5365f8622c3e58a58
Stable URL of this page: https://metraipolis.com/documento/dc_3be38afef8ea

How to cite

JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence — Europe PMC PMID:42459674 — Europe PMC (en), https://europepmc.org/article/MED/42459674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3be38afef8ea (Metraipolis archive dc_3be38afef8ea, sha256 b1aad7627436a4d820ab409663ac5f4d10db3ac6424dead5365f8622c3e58a58)

BibTeX

@misc{dc3be38afef8ea,
  title = {JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence — Europe PMC PMID:42459674},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42459674},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3be38afef8ea; sha256 b1aad7627436a4d820ab409663ac5f4d10db3ac6424dead5365f8622c3e58a58},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459674. Agents can read the archived copy with the MCP tool read_document.